Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization-Reference-Cited by-同舟云学术

Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization

Published:2021-11 Issue: Volume:28 Page:S157-S166
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Hsu Shu-Jung,Xu Xin,Chen Mao-Pei,Zhao Zhi-Ying,Wang Yan,Yin Xin,Zhang Lan,Ge Ning-Ling,Chen Yi,Wang Yan-Hong,Luo Jian-Feng,Ren Zheng-Gang,Chen Rong-Xin^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference50 articles.

1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study;Akinyemiju;Jama Oncol,2015

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park;Liver Int,2015

5. Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease;Kirstein;United Eur Gastroenterol J,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Therapy: HAIC Combined with Tyrosine Kinase Inhibitors and Programmed Cell Death Protein-1 Inhibitors versus HAIC Alone for Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-08

2. Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study;Abdominal Radiology;2024-04-28

3. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes;Journal of Gastrointestinal Oncology;2024-04

4. Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy;Journal of Imaging Informatics in Medicine;2024-02-23

5. Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE;Journal of Gastroenterology and Hepatology;2024-01-19